SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflixs Q3 earnings and guidance are the main focus, with traders watching for signs that engagement, subscriber growth and advertising can offset concerns about content quality, recent layoffs and the content leadership change. Views are split between traders bracing for another post-earnings drop and bulls arguing that pessimism is already reflected in the share price.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Modernas rally is tied to enthusiasm for its Merck-partnered personalized melanoma vaccine after positive Phase 3 topline results, with traders focused on the detailed data presentation at ESMO. Bulls see validation of a broader cancer-vaccine platform and momentum, while bears argue expectations and valuation are stretched and warn of a possible sell-the-news reaction.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Traders are citing a reported ClinicalTrials.gov update adding a site to Sareptas ENHANCE Elevidys safety study as a possible trigger for the rebound, though they note the study timeline reportedly slipped. The broader debate centers on whether upcoming DM1 and FSHD data can support a recovery, with some traders pointing to short covering and others stressing that those clinical results remain unproven.

Sea Ltd. is an internet and mobile platform company, which engages in the provision of online gaming services. It operates through the following segments: Digital Entertainment, E-Commerce, and Digital Financial Services. The Digital Entertainment segment offers and develops mobile and PC online games. The E-Commerce segment manages a third-party marketplace through the Shopee mobile app and websites that connect buyers and sellers. The Digital Financial Services segment includes a variety of payment services and loans to individuals and businesses through SeaMoney. Sea was founded by Xiao Dong Li, Gang Ye, and Jing Ye Chen on May 8, 2009 and is headquartered in Singapore.

Sea Ltd - ADR

Seas plans to pursue a public listing for fintech arm Monee and launch Sea Cloud are fueling concern about spending and uncertainty. Traders largely blame the developments for the selloff, while some see a Monee listing as a potential way to unlock value for shareholders.

GE Aerospace is an American aircraft company, which engages in the provision of jet and turboprop engines, as well as integrated systems for commercial, military, business, and general aviation aircraft. The firm's portfolio of brands includes Avio Aero, Unison, GE Additive, and Dowty Propellers. It operates through the following segments: Commercial Engines and Services, Defense and Propulsion Technologies, and Corporate and Other. The Commercial Engines and Services segment is involved in the design, development, manufacturing, and servicing of jet engines for commercial airframes, as well as business aviation and aeroderivative applications. The Defense and Propulsion Technologies segment offers defense engines and critical aircraft systems. The Corporate and Other segment relates to corporate functions and operations costs. The company was founded by Thomas Alva Edison in 1878 and is headquartered in Evendale, OH.

GE Aerospace

GEs earnings beat and higher outlook have been met with a sharp selloff, prompting traders to question why strong demand and orders are not lifting the shares. The debate centers on rising costs, weaker cash conversion and an insurance loss, while some investors view the reaction as excessive given the improved guidance.

General Motors Co. engages in the designing, manufacturing, and selling of trucks, crossovers, cars, and automobile parts, and in providing software-enabled services and subscriptions. It operates through the following segments: GMNA, GMI, Cruise, and GM Financial. The company was founded by William C. Durant on September 16, 1908 and is headquartered in Detroit, MI.

General Motors Company

GM is drawing attention after its quarterly earnings beat and improved cash-flow outlook failed to prevent a sharp selloff, as traders focused on narrowed full-year profit guidance with no increase to its midpoint. Some see the new buyback and cash generation as support for the shares, while others argue the outlook disappointed despite the strong quarter.

Myriad Genetics, Inc. is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. It develops and commercializes molecular tests that help patients and providers uncover genetic insights. The company was founded by Walter A. Gilbert, Mark H. Skolnick, and Peter D. Meldrum in May 1991 and is headquartered in Salt Lake City, UT.

Myriad Genetics, Inc.

Myriads agreement to sell its prenatal testing business to Labcorp is driving the sharp rally, with traders viewing the cash proceeds as a potential balance-sheet and strategic reset. Others argue the divestiture removes a significant revenue stream and leaves concerns about debt and weakness in the remaining business; the transaction is still pending approval and closing.

The Compound Governance Token is a governance token on the Compound Finance lending protocol, COMP allows the owner to delegate voting rights to the address of their choice; the owner’s wallet, another user, an application, or a DeFi expert. Anybody can participate in Compound governance by receiving delegation, without needing to own COMP.  Anybody with 1% of COMP delegated to their address can propose a governance action; these are simple or complex sets of actions, such as adding support for a new asset, changing an asset’s collateral factor, changing a market’s interest rate model, or changing any other parameter or variable of the protocol that the current administrator can modify.

Compound

A sharp COMP rally and stronger volume have fueled talk of a technical reversal, with traders pointing to chart patterns and a possible breakout. Bulls see renewed momentum, while skeptics question whether the move can hold given COMPs history of lagging other crypto assets.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

Upcoming MSToronto clinical presentations are driving attention, especially initial Phase 1 azer-cel results in progressive MS alongside BRIUMVI data on long-term outcomes and dosing. Traders are broadly optimistic about the catalyst-rich pipeline and BRIUMVIs commercial growth, while some caution that azer-cel is early-stage and debate the stocks muted trading; buyout speculation remains unconfirmed.

Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA.

Rapport Therapeutics Inc.

Rapport Therapeutics Inc

Rapports shares are drawing attention after RAP-219s Phase 2 bipolar-mania trial met its primary and secondary endpoints, prompting bullish reactions and analyst upgrades. Traders are debating whether the efficacy signal is strong enough to justify the surge, citing the modest placebo-adjusted improvement, higher discontinuation rate, and the stocks sharp retreat after its initial jump.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Here's What Key Metrics Tell Us About BOK Financial (BOKF) Q3 Earnings

While the top- and bottom-line numbers for BOK Financial (BOKF) give a sense of how the business performed in the quarter ended September 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

BOK Financial (BOKF) Beats Q3 Earnings Estimates

BOK Financial (BOKF) delivered earnings and revenue surprises of +3.94% and -1.91%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

CFG Stock Up as Q3 Earnings Top Estimates on NII Growth, Dividend Hiked

Citizens Financial stock gains nearly 1% in early trading as Q3 earnings beat estimates on higher NII and improved credit quality, while its dividend rose 13%.

M&T Bank Q3 Earnings Beat on Higher NII, Stock Dips on Cost Woes

MTB beat Q3'26 earnings estimates on higher NII and loan growth, but rising expenses, lower fee income and declining deposits weigh on shares.


Private Bancorp of America, Inc. (PBAM) Q3 Earnings Miss Estimates

Private Bancorp of America (PBAM) delivered earnings and revenue surprises of -4.83% and +2.83%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

Growth in NII & Lower Expenses Likely to Support Fifth Third's Q3 Earnings

FITB is set to report Q3'26 earnings on Oct. 19, with higher NII, lower expenses and loan growth expected to support results.

Texas Capital (TCBI) Expected to Beat Earnings Estimates: Should You Buy?

Texas Capital (TCBI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Stay Ahead of the Game With BOK Financial (BOKF) Q3 Earnings: Wall Street's Insights on Key Metrics

Get a deeper insight into the potential performance of BOK Financial (BOKF) for the quarter ended September 2026 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.

BOK Financial (BOKF) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

BOK Financial (BOKF) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Will BOK Financial (BOKF) Beat Estimates Again in Its Next Earnings Report?

BOK Financial (BOKF) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

$BOKF Q3 &#39;26 Earnings Results &amp; Recap

• Reported GAAP EPS of $2.64 up 19.46% YoY
• Reported revenue of $561.45M up 2.39% YoY

Stocktwits

BOK Financial Corp.

 Q3 '26 Earnings Results & Recap

• Reported GAAP EPS of $2.64 up 19.46% YoY
• Reported revenue of $561.45M up 2.39% YoY

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

• Reported GAAP EPS of $2.64 up 19.46% YoY
• Reported revenue of $561.45M up 2.39% YoY

BOK Financial Corporation faced lower fees as rate conditions reduced trading and mortgage activity, higher nonperforming assets, and a lower tangible common equity ratio alongside larger securities unrealized losses.

BOK Financial Corporation expanded net interest income and margin, grew loans across energy, industrial-facility and mortgage-finance lending, and reported net charge-offs of $886K with no provision for expected credit losses.

https://files.quartr.com/streams/2026-10-20/cbe0d7a4-4fc3-4d4f-8d3c-413f2af8fa4b/1/live_transcript.jsonl?ref=U3RvY2t0d2l0cw==

BOKF  Earnings Call

BOK Financial Corp. is a holding company, which engages in the provision of financial solutions. It operates through the following segments: Commercial Banking, Consumer Banking, Wealth Management, and Funds Management and Other. The Commercial Banking segment includes lending, treasury, and cash management services, as well as customer commodity risk management products for small businesses, middle market, and larger commercial customers. The Consumer Banking segment offers retail lending and deposit services, lending and deposit services to small business customers served through the retail branch network, and all mortgage banking activities. The Wealth Management segment provides fiduciary services, private bank services, and investment advisory services in all markets, as well as underwriting state and municipal securities. The Funds Management and Other segment manages overall liquidity needs and interest rate risks. The company was founded in 1990 and is headquartered in Tulsa, OK.

Bullish Sentiment

Double beat (rev + EPS)

Revenue beat, EPS miss

EPS beat, revenue miss

Double miss

SpaceX ($SPCX) reports earnings after the close today. What do you expect?

SpaceX

) reports earnings after the close today. What do you expect?

Feed

News

Sentiment

Earnings

Fundamentals

Info

BOKF News